Journal of Viral Hepatitis

Cover image for Vol. 11 Issue 1

January 2004

Volume 11, Issue 1

Pages 1–96

  1. Editorial

    1. Top of page
    2. Editorial
    3. Original Articles
    1. Editorial (page 1)

      Howard C Thomas, Graham R Foster and Peter Karayiannis

      Version of Record online: 23 JAN 2004 | DOI: 10.1046/j.1365-2893.2003.00500.x

  2. Original Articles

    1. Top of page
    2. Editorial
    3. Original Articles
    1. Consensus conference on chronic viral hepatitis and HIV infection: updated Spanish recommendations (pages 2–17)

      V. Soriano, J. M. Miró, J. García-Samaniego, J. Torre-Cisneros, M. Núñez, J. Del Romero, L. Martín-Carbonero, J. Castilla, J. A. Iribarren, C. Quereda, M. Santín, J. González, J. R. Arribas, I. Santos, J. Hernández-Quero, E. Ortega, V. Asensi, M. A. Del Pozo, J. Berenguer, C. Tural, B. Clotet, M. Leal, J. Mallolas, J. M. Sánchez-Tapias, S. Moreno, J. M. Gatell, M. J. Téllez, R. Rubio, E. Ledesma, P. Domingo, P. Barreiro, J. Pedreira, M. Romero, J. González-Lahoz and E. Lissen

      Version of Record online: 23 JAN 2004 | DOI: 10.1046/j.1365-2893.2003.00491.x

      • image
      • image
      • image
      • image
    2. DNA immunization encoding the secreted nonstructural protein 3 (NS3) of hepatitis C virus and enhancing the Th1 type immune response (pages 18–26)

      X. Jiao, R. Y.-H. Wang, Z. Feng, G. Hu, H. J. Alter and J. W.-K. Shih

      Version of Record online: 23 JAN 2004 | DOI: 10.1046/j.1352-0504.2003.00464.x

      • image
      • image
      • image
      • image
      • image
      • image
    3. Effect of interferon α and cell cycle progression on translation mediated by the hepatitis C virus 5′ untranslated region: a study using a transgenic mouse model (pages 33–44)

      Y. Takeda, S. Okoshi, K. Suzuki, M. Yano, J. D. Gangemi, G. Jay, H. Asakura and Y. Aoyagi

      Version of Record online: 23 JAN 2004 | DOI: 10.1046/j.1365-2893.2003.00472.x

      • imageimage
      • image
      • image
      • image
      • image
    4. Subtype mutations in the envelope 2 region including phosphorylation homology domain of Hepatitis C virus do not predict effectiveness of antiviral therapy (pages 45–54)

      J. Quer, P. Murillo, M. Martell, J. Gómez, J. I. Esteban, R. Esteban and J. Guardia

      Version of Record online: 23 JAN 2004 | DOI: 10.1046/j.1352-0504.2003.00465.x

      • image
      • image
      • image
      • image
    5. High hepatitis B virus (HBV) DNA viral load is an important risk factor for HBV reactivation in breast cancer patients undergoing cytotoxic chemotherapy (pages 55–59)

      S. Zhong, W. Yeo, C. Schroder, P. K. S. Chan, W.-L. Wong, W. M. Ho, F. Mo, B. Zee and P. J. Johnson

      Version of Record online: 23 JAN 2004 | DOI: 10.1046/j.1352-0504.2003.00467.x

      • image
      • image
    6. Interferon alfa2a induction therapy in combination with ribavirin and amantadine for the treatment of naive patients with chronic HCV infection (pages 60–68)

      S. Engler, C. Flechtenmacher, K. H. Wiedemann, R. Gugler, W. Stremmel and B. Kallinowski

      Version of Record online: 23 JAN 2004 | DOI: 10.1046/j.1352-0504.2003.00463.x

      • image
    7. Thymosin-α 1 plus interferon-α for naive patients with chronic hepatitis C: results of a randomized controlled pilot trial (pages 69–73)

      P. Andreone, A. Gramenzi, C. Cursaro, F. Felline, E. Loggi, A. D'Errico, M. Spinosa, S. Lorenzini, M. Biselli and M. Bernardi

      Version of Record online: 23 JAN 2004 | DOI: 10.1046/j.1365-2893.2003.00470.x

    8. Evolution of hepatitis B viral load and viral genome sequence during adefovir dipivoxil therapy (pages 74–83)

      B. Werle, K. Cinquin, P. Marcellin, S. Pol, M. Maynard, C. Trépo and F. Zoulim

      Version of Record online: 23 JAN 2004 | DOI: 10.1046/j.1365-2893.2003.00471.x

      • image
      • imageimage
      • image
    9. Evidence that plasma concentration rather than dose per kilogram body weight predicts ribavirin-induced anaemia (pages 84–87)

      K. Lindahl, R. Schvarcz, A. Bruchfeld and L. Ståhle

      Version of Record online: 23 JAN 2004 | DOI: 10.1046/j.1365-2893.2003.00475.x

      • image
      • image
    10. Hepatitis B surface antigenaemia following vaccination with a combined vaccine against hepatitis A and B (pages 88–90)

      A. De Schryver, K. De Gendt, G. François, P. Van Damme and A. Meheus

      Version of Record online: 23 JAN 2004 | DOI: 10.1046/j.1365-2893.2003.00473.x

    11. The severity of liver fibrosis is associated with high leptin levels in chronic Hepatitis C (pages 91–96)

      T. Piche, F. Vandenbos, A. Abakar-Mahamat, G. Vanbiervliet, E. M. Barjoan, G. Calle, J. Giudicelli, B. Ferrua, C. Laffont, S. Benzaken and A. Tran

      Version of Record online: 23 JAN 2004 | DOI: 10.1046/j.1365-2893.2003.00483.x

      • image
      • image

SEARCH

SEARCH BY CITATION